43,244 Shares in Caleres, Inc. $CAL Purchased by Semanteon Capital Management LP

Semanteon Capital Management LP acquired a new stake in shares of Caleres, Inc. (NYSE:CAL) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 43,244 shares of the textile maker’s stock, valued at approximately $564,000. Semanteon Capital Management LP owned 0.13% of Caleres at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of CAL. Osaic Holdings Inc. raised its holdings in Caleres by 1,662.8% during the 2nd quarter. Osaic Holdings Inc. now owns 1,992 shares of the textile maker’s stock valued at $25,000 after buying an additional 1,879 shares during the period. CWM LLC increased its position in Caleres by 624.9% during the third quarter. CWM LLC now owns 3,639 shares of the textile maker’s stock valued at $47,000 after acquiring an additional 3,137 shares during the last quarter. State of Wyoming purchased a new stake in shares of Caleres in the third quarter valued at $56,000. New York State Common Retirement Fund lifted its holdings in shares of Caleres by 171.8% in the 3rd quarter. New York State Common Retirement Fund now owns 6,487 shares of the textile maker’s stock worth $85,000 after acquiring an additional 4,100 shares during the last quarter. Finally, Arizona State Retirement System bought a new stake in shares of Caleres in the 3rd quarter worth about $130,000. 98.44% of the stock is owned by institutional investors.

Caleres Stock Performance

Shares of NYSE:CAL opened at $13.08 on Friday. The firm’s 50 day simple moving average is $12.93 and its 200-day simple moving average is $13.11. Caleres, Inc. has a one year low of $9.54 and a one year high of $18.27. The firm has a market cap of $443.24 million, a PE ratio of 20.75 and a beta of 0.64.

Caleres (NYSE:CAL) last posted its quarterly earnings results on Tuesday, December 9th. The textile maker reported $0.67 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.08). Caleres had a return on equity of 8.62% and a net margin of 0.78%.The firm had revenue of $790.05 million for the quarter, compared to the consensus estimate of $768.59 million. During the same period in the previous year, the company posted $1.23 EPS. Caleres’s quarterly revenue was up 6.6% compared to the same quarter last year. Caleres has set its FY 2025 guidance at 0.550-0.60 EPS. Equities research analysts predict that Caleres, Inc. will post 3.23 EPS for the current fiscal year.

Caleres Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 26th were paid a $0.07 dividend. The ex-dividend date of this dividend was Friday, December 26th. This represents a $0.28 dividend on an annualized basis and a yield of 2.1%. Caleres’s payout ratio is 44.44%.

Wall Street Analyst Weigh In

Several brokerages recently commented on CAL. Zacks Research downgraded shares of Caleres from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 28th. Weiss Ratings restated a “sell (d+)” rating on shares of Caleres in a research report on Wednesday, January 21st. One analyst has rated the stock with a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Sell” and a consensus target price of $14.00.

About Caleres

Caleres, Inc, formerly known as Brown Shoe Company, is a leading footwear company engaged in the design, sourcing, marketing and selling of a broad portfolio of branded and private-label shoes. The company’s operations span a range of market segments from value-priced to premium and luxury. Caleres operates through two primary segments: a retail segment anchored by the Famous Footwear banner, which includes more than 1,100 stores across North America, and a brand portfolio segment comprising owned and licensed brands such as Allen Edmonds, Naturalizer, Sam Edelman, Dr.